Eli Lilly’s stock tumbles as Mounjaro, Zepbound sales miss expectations by wide margins

By MarketWatch | Created at 2024-10-30 11:03:07 | Updated at 2024-10-30 15:26:37 4 hours ago
Truth

Please enable JS and disable any ad blocker

Read Entire Article